168 related articles for article (PubMed ID: 37638016)
1. Activation and pro-inflammatory cytokine production by unswitched memory B cells during SARS-CoV-2 infection.
Castleman MJ; Santos AL; Lesteberg KE; Maloney JP; Janssen WJ; Mould KJ; Beckham JD; Pelanda R; Torres RM
Front Immunol; 2023; 14():1213344. PubMed ID: 37638016
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies elicited with SARS-CoV-2 infection are linked to alterations in double negative B cells.
Castleman MJ; Stumpf MM; Therrien NR; Smith MJ; Lesteberg KE; Palmer BE; Maloney JP; Janssen WJ; Mould KJ; Beckham JD; Pelanda R; Torres RM
Front Immunol; 2022; 13():988125. PubMed ID: 36131937
[TBL] [Abstract][Full Text] [Related]
3. Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration.
Newell KL; Clemmer DC; Cox JB; Kayode YI; Zoccoli-Rodriguez V; Taylor HE; Endy TP; Wilmore JR; Winslow GM
PLoS One; 2021; 16(1):e0244855. PubMed ID: 33507994
[TBL] [Abstract][Full Text] [Related]
4. Increased Frequency of Activated Switched Memory B Cells and Its Association With the Presence of Pulmonary Fibrosis in Diffuse Cutaneous Systemic Sclerosis Patients.
Simon D; Balogh P; Erdő-Bonyár S; Böröcz K; Minier T; Czirják L; Berki T
Front Immunol; 2021; 12():686483. PubMed ID: 34276673
[TBL] [Abstract][Full Text] [Related]
5. Switched and unswitched memory B cells detected during SARS-CoV-2 convalescence correlate with limited symptom duration.
Newell KL; Clemmer DC; Cox JB; Kayode YI; Zoccoli-Rodriguez V; Taylor HE; Endy TP; Wilmore JR; Winslow G
medRxiv; 2020 Sep; ():. PubMed ID: 32908991
[TBL] [Abstract][Full Text] [Related]
6. Primary Sjögren's syndrome is characterized by distinct phenotypic and transcriptional profiles of IgD+ unswitched memory B cells.
Roberts ME; Kaminski D; Jenks SA; Maguire C; Ching K; Burbelo PD; Iadarola MJ; Rosenberg A; Coca A; Anolik J; Sanz I
Arthritis Rheumatol; 2014 Sep; 66(9):2558-69. PubMed ID: 24909310
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm.
Garcia MA; Barreras PV; Lewis A; Pinilla G; Sokoll LJ; Kickler T; Mostafa H; Caturegli M; Moghekar A; Fitzgerald KC; ; Pardo CA
J Neurol Sci; 2021 Aug; 427():117517. PubMed ID: 34090021
[TBL] [Abstract][Full Text] [Related]
8. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2-specific antibody and T-cell responses 1 year after infection in people recovered from COVID-19: a longitudinal cohort study.
Guo L; Wang G; Wang Y; Zhang Q; Ren L; Gu X; Huang T; Zhong J; Wang Y; Wang X; Huang L; Xu L; Wang C; Chen L; Xiao X; Peng Y; Knight JC; Dong T; Cao B; Wang J
Lancet Microbe; 2022 May; 3(5):e348-e356. PubMed ID: 35345417
[TBL] [Abstract][Full Text] [Related]
10. Immune response to SARS-CoV-2 mRNA vaccination in multiple sclerosis patients after rituximab treatment interruption.
Gröning R; Dernstedt A; Ahlm C; Normark J; Sundström P; Forsell MNE
Front Immunol; 2023; 14():1219560. PubMed ID: 37575257
[TBL] [Abstract][Full Text] [Related]
11. Monocytic-Myeloid Derived Suppressor Cells Suppress T-Cell Responses in Recovered SARS CoV2-Infected Individuals.
Beliakova-Bethell N; Maruthai K; Xu R; Salvador LCM; Garg A
Front Immunol; 2022; 13():894543. PubMed ID: 35812392
[TBL] [Abstract][Full Text] [Related]
12. Metabolic Reprogramming Commits Differentiation of Human CD27
Torigoe M; Iwata S; Nakayamada S; Sakata K; Zhang M; Hajime M; Miyazaki Y; Narisawa M; Ishii K; Shibata H; Tanaka Y
J Immunol; 2017 Jul; 199(2):425-434. PubMed ID: 28626065
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.
Pantazi I; Al-Qahtani AA; Alhamlan FS; Alothaid H; Matou-Nasri S; Sourvinos G; Vergadi E; Tsatsanis C
Front Immunol; 2021; 12():683800. PubMed ID: 34248968
[TBL] [Abstract][Full Text] [Related]
14. SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases.
Larionova R; Byvaltsev K; Kravtsova О; Takha E; Petrov S; Kazarian G; Valeeva A; Shuralev E; Mukminov M; Renaudineau Y; Arleevskaya M
J Transl Autoimmun; 2022; 5():100154. PubMed ID: 35434592
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV2 Infection During Pregnancy Causes Persistent Immune Abnormalities in Women Without Affecting the Newborns.
Vazquez-Alejo E; Tarancon-Diez L; Carrasco I; Vigil-Vázquez S; Muñoz-Chapuli M; Rincón-López E; Saavedra-Lozano J; Santos-Sebastián M; Aguilera-Alonso D; Hernanz-Lobo A; Santiago-García B; de León-Luis JA; Muñoz P; Sánchez-Luna M; Navarro ML; Muñoz-Fernández MÁ
Front Immunol; 2022; 13():947549. PubMed ID: 35911743
[TBL] [Abstract][Full Text] [Related]
16. Characterization of memory T cell subsets and common γ-chain cytokines in convalescent COVID-19 individuals.
Rajamanickam A; Pavan Kumar N; Pandiaraj AN; Selvaraj N; Munisankar S; Renji RM; Venkataramani V; Murhekar M; Thangaraj JWV; Muthusamy SK; Chethrapilly Purushothaman GK; Bhatnagar T; Ponnaiah M; Ramasamy S; Velusamy S; Babu S
J Leukoc Biol; 2022 Jul; 112(1):201-212. PubMed ID: 35258122
[TBL] [Abstract][Full Text] [Related]
17. Tumor Necrosis Factor-Alpha Exacerbates Viral Entry in SARS-CoV2-Infected iPSC-Derived Cardiomyocytes.
Lee CY; Huang CH; Rastegari E; Rengganaten V; Liu PC; Tsai PH; Chin YF; Wu JR; Chiou SH; Teng YC; Lee CW; Liang Y; Chen AY; Hsu SC; Hung YJ; Sun JR; Chien CS; Chien Y
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576032
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of the pro-inflammatory cytokine signature in severe COVID-19.
Hawerkamp HC; Dyer AH; Patil ND; McElheron M; O'Dowd N; O'Doherty L; Mhaonaigh AU; George AM; O'Halloran AM; Reddy C; Kenny RA; Little MA; Martin-Loeches I; Bergin C; Kennelly SP; Donnelly SC; Bourke NM; Long A; Sui J; Doherty DG; Conlon N; Cheallaigh CN; Fallon PG
Front Immunol; 2023; 14():1170012. PubMed ID: 37063871
[TBL] [Abstract][Full Text] [Related]
19. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.
Nayak B; Lal G; Kumar S; Das CJ; Saraya A; Shalimar
Front Cell Infect Microbiol; 2021; 11():753249. PubMed ID: 34760721
[TBL] [Abstract][Full Text] [Related]
20. Myoclonus status revealing COVID 19 infection.
Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
